Blue Jet Healthcare
BLUEJET · Pharma > Pharmaceuticals & Drugs Listing date: Nov. 1, 2023

Stock Price vs Company Growth
1d
1.6%
1w
4.0%
1m
19.2%
3m
23.7%
6m
48.1%
1y
85.5%
all
48.4%
Created with Highcharts 8.2.2SalesProfitPriceDividendQtr SalesOperating CashflowDec22Jun23Dec23Jun24Latest

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

711 1.6%
571
969
Company Overview

Sales
873 Cr
Growth: -0.3%
Profit after Tax
235 Cr
Growth: 39.8%
Mid Cap
12,338 Cr
P/E: 52.5x
Industry P/E: 31.8x
Created with Highcharts 8.2.2HistoricalGrowthValuationAttractivenessProfitabilityIndustryOutlookPriceStability10
Fundamentals

Sales (Cr) ₹ 873
Growth -0.3%
EBITDA 33.3%
P/S 14.1x
Dividend 0.2%
P/E 52.5x
Book Value ₹ 60
PEG Ratio -172.5x
ROE 25.3%
P/B 11.8x
Shareholding Pattern

Increase    Decrease    No change
Company Profile Detailed

The company is a global, science-led, pharmaceutical company evolved as Strategic Partner for Collaboration, Development & Manufacturing of advance Pharmaceutical Intermediates and API.
Followers (1)